Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Onco-Innovations Ltd. ( (TSE:ONCO) ) has issued an update.
Onco-Innovations Limited announced that its non-brokered private placement of up to 408,164 units, aimed at raising $1,000,000, has been fully subscribed, indicating strong investor confidence in the company. The closing is expected around January 31, 2025, with issued securities subject to a hold period as per applicable laws, potentially enhancing the company’s financial position in its mission to advance cancer treatment solutions.
More about Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company specializing in oncology, focusing on cancer research and treatment. The company aims to prevent and cure cancer through pioneering research and innovative solutions, holding an exclusive worldwide license to patented technology targeting solid tumors.
YTD Price Performance: 172.94%
Average Trading Volume: 401,783
For an in-depth examination of ONCO stock, go to TipRanks’ Stock Analysis page.
